Atlas Trials

Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial

Clinical trial NCT06022822 · RECRUITING

Trial details

NCT number
NCT06022822
Sponsor
National Cancer Institute (NCI)
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Adenocarcinoma
Start date
2024-09-12
Primary completion
2026-11-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.